• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Talkspace Announces First Quarter 2025 Results

    5/6/25 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care
    Get the next $TALK alert in real time by email

    1Q 2025 Total revenue grew 15% year-over-year to $52.2 million 

    driven by 33% year-over-year growth in Payor revenue

    1Q 2025 Net income of $0.3 million and adjusted EBITDA1 of $2.0 million

    1Q 2025 Share repurchases of $7.0 million

    NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Talkspace, Inc. ("Talkspace" or the "Company") (NASDAQ:TALK), today reported first quarter 2025 financial results.

      Three Months Ended

    March 31, 2025
     
        
    Unaudited Results % Variance from

    Prior Year
     
    (In thousands unless otherwise noted)     
    Number of completed Payor sessions during the period  350.0  23% 
    Number of Unique Active Payor members during the period  101.2  17% 
          
    Total revenue $52,182  15% 
    Gross profit $23,281  7% 
    Gross margin %  44.6%   
    Operating expenses $24,366  4% 
    Net income $318 * 
    Adjusted EBITDA (1) $1,955  153% 
    Cash and cash equivalents at period end $60,077  — 
    Short-term marketable securities $48,274  — 
            
    * Percentage not meaningful.
     
    (1) Adjusted EBITDA is a non-GAAP financial measure. For a definition of the measure and a reconciliation to the most direct comparable GAAP measure, see "Reconciliation of GAAP Results to Non-GAAP Results."
     

    Dr. Jon Cohen, CEO of Talkspace, said, "I'm pleased with our first quarter performance as we continue to execute on our mission to make high-quality mental health care accessible, affordable, and available at scale. This Mental Health Awareness Month, we reaffirm our commitment to breaking down barriers to care for millions of Americans through our ‘Let's Face It' campaign, highlighting the ways our platform empowers members to overcome obstacles to their mental health. The progress we've made in driving both growth and profitability, while continuously innovating and enhancing our product demonstrates the sustainability of our model."

    First Quarter 2025 Key Performance Metrics

    • Revenue increased 15% over the prior-year period to $52.2 million, driven by a 33% year-over-year increase in Payor revenue, partially offset by a 32% year-over-year decline in Consumer revenue.
    • Gross profit increased 7% over the prior-year period to $23.3 million, and gross margin declined to 44.6% from 47.8% in the prior-year period, driven by a shift in revenue mix towards Payor.
    • Operating expenses were $24.4 million, an increase of 4% year-over-year.
    • Net income was $0.3 million, an improvement from $(1.5) million net loss in the first quarter of 2024, primarily driven by an increase in revenues, partially offset by an increase in cost of revenues.
    • Adjusted EBITDA was $2.0 million, an improvement from $0.8 million adjusted EBITDA in the first quarter of 2024, primarily driven by an increase in revenues, partially offset by an increase in cost of revenues.

    Financial Guidance

    The following guidance is based on current market conditions and expectations and the information available to the Company today. For 2025 Talkspace continues to expect:

    • Revenue to be in the range of $220 million to $235 million
    • Adjusted EBITDA to be in the range of $14 million to $20 million

    Conference Call, Presentation Slides, and Webcast Details

    The First Quarter 2025 earnings conference call and webcast will be held Tuesday, May 6, 2025, at 8:30 a.m. E.T. The conference call will be available via audio webcast at investors.talkspace.com and can also be accessed by dialing (888) 596-4144 for U.S. participants, or +1 (646) 968-2525 for international participants, and referencing participant code 1021845. A replay will be available shortly after the call's completion and remain available for approximately 90 days.

    About Talkspace

    Talkspace (NASDAQ:TALK) is a leading virtual behavioral healthcare provider committed to helping people lead healthier, happier lives through access to high-quality mental healthcare. At Talkspace, we believe that mental healthcare is core to overall health and should be available to everyone.

    Talkspace pioneered the ability to text with a licensed therapist from anywhere and now offers a comprehensive suite of mental health services, including therapy for individuals, teens, and couples, as well as psychiatric treatment and medication management (18+). With Talkspace's core therapy offerings, members are matched with one of thousands of licensed therapists within days and can engage in live video, audio, or chat sessions, and/or unlimited asynchronous text messaging sessions.

    All care offered at Talkspace is delivered through an easy-to-use, fully-encrypted web and mobile platform that meets HIPAA, federal, and state regulatory requirements. Most Americans have access to Talkspace through their health insurance plans, employee assistance programs, our partnerships with leading healthcare companies, or as a free benefit through their employer, school, or government agency.

    For more information, visit www.talkspace.com.

    For Investors:

    ICR Westwicke

    [email protected]

    For Media:

    Talkspace Communications Team

    [email protected]

    Forward Looking Statements

    This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking, including statements regarding our financial condition, anticipated financial performance, achieving profitability, business strategy and plans, market opportunity and expansion and objectives of our management for future operations. These forward-looking statements generally are identified by the words "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "forecast," "future," "intend," "may," "might," "opportunity," "plan," "possible," "potential," "predict," "project," "should," "strategy," "strive," "target," "will," or "would," the negative of these words or other similar terms or expressions. The absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many important factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: (i) rapid technological change in our industry; (ii) our ability to secure clients' contract renewals; (iii) our ability to maintain and expand our network of therapists, psychiatrists and other providers; (iv) a decline in the prevalence of enterprise-sponsored healthcare or the emergence of new technologies may adversely impact our DTE business; (v) if our or our vendors' security measures fail or are breached; (vi) changes in healthcare laws, regulations or trends and our ability to operate in the heavily regulated healthcare industry; and (vii) and the other factors, risks and uncertainties described under the caption "Risk Factors" in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on March 12, 2025, subsequent quarterly reports on Form 10-Q and our other documents filed from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and we assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise unless required to do so under applicable law. We do not give any assurance that we will achieve our expectations.



     
    Talkspace, Inc.

    Condensed Consolidated Statements of Income

    (Unaudited)
     
      Three Months Ended

    March 31,
        
      2025  2024  % Change 
    (in thousands, except percentages, share and per share data)         
    Revenue:         
    Payor revenue $37,842  $28,508   32.7 
    DTE revenue  9,583   9,913   (3.3) 
    Consumer revenue  4,757   6,995   (32.0) 
    Total revenue  52,182   45,416   14.9 
    Cost of revenues  28,901   23,685   22.0 
    Gross profit  23,281   21,731   7.1 
    Operating expenses:         
    Research and development  3,319   3,739   (11.2) 
    Clinical operations, net  1,856   1,464   26.8 
    Sales and marketing  13,984   13,009   7.5 
    General and administrative  5,207   5,198   0.2 
    Total operating expenses  24,366   23,410   4.1 
    Loss from operations  (1,085)   (1,679)   (35.4) 
    Financial income, net  (1,526)   (378)   (303.7) 
    Income (loss) before income taxes  441   (1,301)  * 
    Income tax expense  123   165   (25.5) 
    Net income (loss) $318  $(1,466)  * 
    Net income (loss) per share:         
    Basic $0.00  $(0.01)  * 
    Diluted $0.00  $(0.01)  * 
    Weighted average shares used to compute net income (loss) per share:         
    Basic  168,670,861   168,846,946    
    Diluted  175,545,887   168,846,946    
                
    * Percentage not meaningful.
                



     
    Talkspace, Inc.

    Condensed Consolidated Statements of Comprehensive Income (Loss)

    (Unaudited)
     
      Three Months Ended

    March 31,
        
      2025  2024  % Change 
              
    (in thousands)         
    Net income (loss) $318  $(1,466)  * 
    Other comprehensive income:         
    Change in unrealized gains on marketable debt securities  25   —   100.0 
    Total other comprehensive income  25   —   100.0 
    Total comprehensive income (loss) $343  $(1,466)  * 
                
    * Percentage not meaningful.
                



     
    Talkspace, Inc.

    Condensed Consolidated Balance Sheets
     
        
      March 31, 2025  December 31, 2024 
    (in thousands) Unaudited    
    ASSETS      
    CURRENT ASSETS:      
    Cash and cash equivalents $60,077  $76,692 
    Marketable securities  48,274   41,118 
    Accounts receivable, net  13,249   9,643 
    Other current assets  2,519   2,729 
    Total current assets  124,119   130,182 
    Fixed assets, net  8,016   6,259 
    Other long-term assets  2,110   2,236 
    Total assets $134,245  $138,677 
    LIABILITIES AND STOCKHOLDERS' EQUITY      
    CURRENT LIABILITIES:      
    Accounts payable $10,526  $7,710 
    Accrued expenses and other current liabilities  4,744   8,031 
    Deferred revenues  3,849   3,282 
    Total current liabilities  19,119   19,023 
    Warrant liabilities  1,206   1,690 
    Other liabilities  502   569 
    Total liabilities  20,827   21,282 
    STOCKHOLDERS' EQUITY:      
    Common stock  17   17 
    Additional paid-in capital  382,292   386,612 
    Accumulated deficit  (268,918)   (269,236) 
    Accumulated other comprehensive income  27   2 
    Total stockholders' equity  113,418   117,395 
    Total liabilities and stockholders' equity $134,245  $138,677 



     
    Talkspace, Inc.

    Condensed Consolidated Statements of Cash Flows

    (Unaudited)
     
      Three Months Ended

    March 31,
     
      2025  2024 
    (in thousands)      
    Cash flows from operating activities:      
    Net income (loss) $318  $(1,466) 
    Adjustments to reconcile net income (loss) to net cash used in operating activities:      
    Depreciation and amortization  666   201 
    Accretion of marketable securities  (176)   — 
    Stock-based compensation  2,333   2,252 
    Remeasurement of warrant liabilities  (484)   1,146 
    Increase in accounts receivable  (3,606)   (861) 
    Decrease in other current assets  210   1,301 
    Increase (decrease) in accounts payable  2,816   (306) 
    Increase (decrease) in deferred revenues  567   (186) 
    Decrease in accrued expenses and other current liabilities  (3,798)   (5,470) 
    Other  (85)   (2) 
    Net cash used in operating activities  (1,239)   (3,391) 
    Cash flows from investing activities:      
    Purchases of marketable securities  (10,428)   — 
    Proceeds from maturities of marketable securities  3,430   — 
    Capitalized internal-use software costs  (1,997)   (366) 
    Other  (24)   (19) 
    Net cash used in investing activities  (9,019)   (385) 
    Cash flows from financing activities:      
    Proceeds from exercise of stock options  678   741 
    Payments for employee taxes withheld related to vested stock-based awards  (571)   (595) 
    Repurchase of common stock for retirement  (6,464)   — 
    Net cash (used in) provided by financing activities  (6,357)   146 
    Net decrease in cash and cash equivalents  (16,615)   (3,630) 
    Cash and cash equivalents at the beginning of the period  76,692   123,908 
    Cash and cash equivalents at the end of the period $60,077  $120,278 



    Non-GAAP Financial Measures

    In addition to our financial results determined in accordance with GAAP, we believe adjusted EBITDA, a non-GAAP measure, is useful in evaluating our operating performance, and our management uses it as a key performance measure to assess our operating performance. Because adjusted EBITDA facilitates internal comparisons of our historical operating performance on a more consistent basis, we use this measure for business planning purposes and in evaluating acquisition opportunities. We also use adjusted EBITDA to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that this non-GAAP financial measure, when taken together with the corresponding GAAP financial measures, provides meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our business, results of operations or outlook. We believe that the use of adjusted EBITDA is helpful to our investors as it is a metric used by management in assessing the health of our business and our operating performance. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP.

    Some of the limitations of adjusted EBITDA include (i) adjusted EBITDA does not necessarily reflect capital commitments to be paid in the future and (ii) although depreciation and amortization are non-cash charges, the underlying assets may need to be replaced and adjusted EBITDA does not reflect these requirements. In evaluating adjusted EBITDA, you should be aware that in the future we will incur expenses similar to the adjustments described herein. Our presentation of adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these expenses or any unusual or non-recurring items. Our adjusted EBITDA may not be comparable to similarly titled measures of other companies because they may not calculate adjusted EBITDA in the same manner as we calculate the measure, limiting its usefulness as a comparative measure. Adjusted EBITDA should not be considered as an alternative to income (loss) before income taxes, net income (loss), income (loss) per share, or any other performance measures derived in accordance with U.S. GAAP. When evaluating our performance, you should consider adjusted EBITDA alongside other financial performance measures, including our net income (loss) and other GAAP results.

    A reconciliation is provided below for adjusted EBITDA to net income (loss), the most directly comparable financial measure stated in accordance with GAAP. Investors are encouraged to review our financial statements prepared in accordance with GAAP and the reconciliation of our non-GAAP financial measure to its most directly comparable GAAP financial measure, and not to rely on any single financial measure to evaluate our business. We do not provide a forward-looking reconciliation of adjusted EBITDA guidance as the amount and significance of the reconciling items required to develop meaningful comparable GAAP financial measures cannot be estimated at this time without unreasonable efforts. These reconciling items could be meaningful.

    Adjusted EBITDA

    We calculate adjusted EBITDA as net income (loss) adjusted to exclude (i) depreciation and amortization, (ii) stock-based compensation expense, (iii) financial income, net, (iv) income tax expense, and (v) certain non-recurring expenses, where applicable.

    Talkspace, Inc.

    Reconciliation of GAAP Results to Non-GAAP Results

    (Unaudited)
     
      Three Months Ended

    March 31,
     
      2025  2024 
    (in thousands)      
    Net income (loss) $318  $(1,466) 
    Add:      
    Depreciation and amortization  649   201 
    Stock-based compensation  2,333   2,252 
    Financial income, net  (1,526)   (378) 
    Income tax expense  123   165 
    Non-recurring expenses  58   — 
    Adjusted EBITDA $1,955  $774 


    Primary Logo

    Get the next $TALK alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TALK

    DatePrice TargetRatingAnalyst
    4/3/2025$5.00Buy
    Canaccord Genuity
    12/9/2024$4.50Overweight
    KeyBanc Capital Markets
    12/4/2024$5.00Outperform
    Mizuho
    11/20/2024$5.00Outperform
    Northland Capital
    7/1/2024Hold
    Needham
    1/3/2024$2.50Equal Weight
    Barclays
    12/2/2021$2.00Hold
    Jefferies
    11/16/2021$10.00 → $3.00Outperform → Neutral
    Robert W. Baird
    More analyst ratings

    $TALK
    Financials

    Live finance-specific insights

    See more
    • Talkspace Announces First Quarter 2025 Results

      1Q 2025 Total revenue grew 15% year-over-year to $52.2 million driven by 33% year-over-year growth in Payor revenue 1Q 2025 Net income of $0.3 million and adjusted EBITDA1 of $2.0 million 1Q 2025 Share repurchases of $7.0 million NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Talkspace, Inc. ("Talkspace" or the "Company") (NASDAQ:TALK), today reported first quarter 2025 financial results.   Three Months Ended March 31, 2025     Unaudited Results % Variance fromPrior Year (In thousands unless otherwise noted)     Number of completed Payor sessions during the period  350.0  23% Number of Unique Active Payor members during the period  101.2  17%       Total revenue $52,182  15% G

      5/6/25 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace to Report First Quarter 2025 Results and Host Conference Call

      NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- Talkspace (NASDAQ:TALK), a leading behavioral healthcare company, today announced that it will release its first quarter 2025 results on Tuesday, May 6, 2025, before market open and host a conference call to review the results at 8:30am ET. Conference Call DetailsThe conference call will be available via audio webcast at https://investors.talkspace.com/ and can also be accessed by dialing (888) 596-4144 for U.S. participants, or +1 (646) 968-2525 for international participants, and referencing participant code 1021845. A replay will be available shortly after the call's completion and remain available for approximately 90 days. About Talkspace

      4/16/25 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace Announces Fourth Quarter and Full Year 2024 Results

      Full year 2024 total revenue grew 25% year-over-year to $187.6 millionFull year 2024 net income of $1.1 million and adjusted EBITDA1 of $7.0 million 4Q 2024 total revenue grew 15% year-over-year to $48.7 million4Q 2024 net income of $1.2 million and adjusted EBITDA1 of $2.7 million NEW YORK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Talkspace, Inc. ("Talkspace" or the "Company") (NASDAQ:TALK), today reported fourth quarter and full year 2024 financial results.     Three Months Ended December 31, 2024 Year Ended December 31, 2024     Unaudited Results % Variance from Prior Year Results % Variance from Prior Year(In thousands unless otherwise noted)        Number of eligible lives at ye

      2/20/25 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Harris Ian Jiro bought $86,037 worth of shares (30,844 units at $2.79), increasing direct ownership by 5% to 615,015 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      3/5/25 4:00:06 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Chief Executive Officer Cohen Jon R bought $214,500 worth of shares (75,000 units at $2.86), increasing direct ownership by 3% to 2,267,980 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      3/3/25 9:30:03 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Chief Legal Officer, Secretary Reilly John Charles bought $10,242 worth of shares (3,600 units at $2.85), increasing direct ownership by 0.41% to 889,806 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      2/28/25 9:55:04 PM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    Leadership Updates

    Live Leadership Updates

    See more
    • Talkspace Partners With Amazon Health Services to Help Millions Discover Mental Health Benefits

      New collaboration aims to improve awareness of, and expand access to, online therapy and psychiatry services to the 150+ million people who have Talkspace as a covered benefit Talkspace (NASDAQ:TALK), a leading online behavioral health care company, today announced a partnership with Amazon Health Services to increase awareness and discoverability of its mental health care services on Amazon.com. Talkspace is the first virtual behavioral health provider to join Amazon Health Services' program to help individuals discover and enroll in their health insurance benefits at no extra cost or for a small copay. With more than 5,000 therapists and providers across 50 states, Talkspace improves acc

      9/17/24 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace and the Professional Tennis Players Association Join Forces to Support Mental Health of Athletes Year Round

      Today, Talkspace (NASDAQ:TALK), a leading online behavioral health care company, announced its partnership with the Professional Tennis Players Association (PTPA), global advocates for professional tennis players. Talkspace will serve as the PTPA's exclusive mental health technology partner, granting players, their families, and their support teams free, 24/7 access to Talkspace's self-guided therapy app, Talkspace Go, as well as discounted access to its virtual therapy offering. "Talkspace is honored to join forces with the PTPA as its exclusive mental health provider, dedicated to delivering high-quality, evidence-based support where and when players need it. This collaboration undersco

      8/28/24 9:06:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace Appoints John Mooney as Chief Product Officer

      NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Today Talkspace (NASDAQ:TALK), a leading online behavioral health care company, announced the appointment of John Mooney as its new Chief Product Officer, to lead the company's growth initiatives, product strategy and design. Through his work for startup digital health, behavioral health, and diagnostics companies, Mr. Mooney has deep domain expertise in healthcare data, building out platform capabilities and optimizing workflows. "John has spent his career driving innovation for a range of high-growth, high-performing healthcare companies," said Dr. Jon Cohen, Chief Executive Officer, Talkspace. "We look forward to his expertise leveraging dat

      6/5/24 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    SEC Filings

    See more
    • SEC Form 10-Q filed by Talkspace Inc.

      10-Q - Talkspace, Inc. (0001803901) (Filer)

      5/9/25 8:38:38 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Talkspace, Inc. (0001803901) (Filer)

      5/6/25 8:15:44 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • SEC Form DEFA14A filed by Talkspace Inc.

      DEFA14A - Talkspace, Inc. (0001803901) (Filer)

      4/30/25 5:26:18 PM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Canaccord Genuity initiated coverage on Talkspace with a new price target

      Canaccord Genuity initiated coverage of Talkspace with a rating of Buy and set a new price target of $5.00

      4/3/25 8:18:33 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • KeyBanc Capital Markets initiated coverage on Talkspace with a new price target

      KeyBanc Capital Markets initiated coverage of Talkspace with a rating of Overweight and set a new price target of $4.50

      12/9/24 8:34:29 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Mizuho initiated coverage on Talkspace with a new price target

      Mizuho initiated coverage of Talkspace with a rating of Outperform and set a new price target of $5.00

      12/4/24 7:49:48 AM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Cohen Jon R covered exercise/tax liability with 53,601 shares, decreasing direct ownership by 2% to 2,573,060 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      3/11/25 8:00:16 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Chief Marketing Officer Watson Katelyn covered exercise/tax liability with 2,779 shares, decreasing direct ownership by 0.58% to 472,997 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      3/11/25 8:00:13 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Chief Legal Officer, Secretary Reilly John Charles covered exercise/tax liability with 12,521 shares, decreasing direct ownership by 1% to 1,040,035 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      3/11/25 8:00:08 PM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Navigate Drives Continued Momentum in its Partner Ecosystem; Adds Talkspace, movr, and Springbuk

      WEST DES MOINES, Iowa, May 7, 2025 /PRNewswire/ -- Navigate Wellbeing Solutions announced strategic partnerships with Talkspace (NASDAQ:TALK), movr, and Springbuk, adding significant strength to its partner ecosystem. These leading solutions address three of the most urgent and costly areas in workforce health: mental health, musculoskeletal (MSK) care, and population health intelligence. "Employers are no longer willing to take a trial-and-error approach to employee health benefits," stated Troy Vincent, Founder and CEO of Navigate Wellbeing Solutions. "Our wellbeing solution

      5/7/25 11:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace Announces First Quarter 2025 Results

      1Q 2025 Total revenue grew 15% year-over-year to $52.2 million driven by 33% year-over-year growth in Payor revenue 1Q 2025 Net income of $0.3 million and adjusted EBITDA1 of $2.0 million 1Q 2025 Share repurchases of $7.0 million NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Talkspace, Inc. ("Talkspace" or the "Company") (NASDAQ:TALK), today reported first quarter 2025 financial results.   Three Months Ended March 31, 2025     Unaudited Results % Variance fromPrior Year (In thousands unless otherwise noted)     Number of completed Payor sessions during the period  350.0  23% Number of Unique Active Payor members during the period  101.2  17%       Total revenue $52,182  15% G

      5/6/25 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace and Bark Technologies Partner to Equip Teens with Essential Mental Health Resources Right from Their Bark Phones

        Talkspace (NASDAQ:TALK), a leading online behavioral healthcare company, and Bark Technologies, the leader in online safety tech for kids, announced they will join forces to help families navigate the many challenges facing teens today. Starting May 1, this new partnership will make Talkspace's high-quality mental health resources available to Bark Phone and Bark app users, as well as provide an enterprise-level solution that leverages their unique capabilities. Talkspace complements Bark's advanced content monitoring, which helps families detect potential dangers in their children's online activities, putting mental health support at their fingertips by connecting teens (13+) to resou

      4/29/25 9:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Talkspace Inc. (Amendment)

      SC 13G/A - Talkspace, Inc. (0001803901) (Subject)

      2/14/24 4:24:23 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Talkspace Inc. (Amendment)

      SC 13G/A - Talkspace, Inc. (0001803901) (Subject)

      2/9/24 7:24:33 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13D/A filed by Talkspace Inc. (Amendment)

      SC 13D/A - Talkspace, Inc. (0001803901) (Subject)

      10/5/23 6:41:35 PM ET
      $TALK
      Medical/Nursing Services
      Health Care